Otonomy to Present at Raymond James 2020 Human Health Innovation Conference
June 11, 2020 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, June 11, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy to Host Pipeline Program Update Conference Call and Webcast
June 08, 2020 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, June 08, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Otonomy and AGTC Present Preclinical Results Supporting Selection of Product Candidate for GJB2 Gene Therapy Hearing Loss Program
May 12, 2020 08:00 ET
|
Otonomy, Inc.
SAN DIEGO, May 12, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
Otonomy Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 07, 2020 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, May 07, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported...
COVID-19 Pandemic Exposes Troubling Gap in Healthcare System
May 06, 2020 13:10 ET
|
Starkey Hearing Technologies
Eden Prairie, Minnesota, May 06, 2020 (GLOBE NEWSWIRE) -- Since the beginning of the COVID-19 health crisis, clear communication has been vitally important for the safety of people around the world....
Phonak partners with VA to expand telehealth access
May 05, 2020 13:53 ET
|
Phonak
Warrenville, IL, May 05, 2020 (GLOBE NEWSWIRE) -- Leading hearing health care company Phonak has partnered with the United States Department of Veterans Affairs (VA) to make remote hearing care,...
New telehealth technology from Phonak will enable fully-remote hearing aid fittings
April 30, 2020 10:01 ET
|
Phonak
Stäfa, Switzerland, April 30, 2020 (GLOBE NEWSWIRE) -- Phonak is responding to the immediate need for those with hearing loss to receive essential care amid the COVID-19 pandemic with...
Otonomy Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
February 27, 2020 16:15 ET
|
Otonomy, Inc.
Results from three clinical trials expected in 2020 including the Phase 3 trial of OTIVIDEX™ in Ménière’s diseaseCurrent capital funds operations into 2021 Conference call and webcast today at 4:30...
Otonomy to Present at Two Upcoming Investor Conferences
February 24, 2020 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
February 20, 2020 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...